The ROSE criteria for coexistent COPD-bronchiectasis: association with future exacerbations and death
W. Dolliver (Boston, MA, United States), W. Wang (Boston, MA, United States), J. Orejas (Boston, MA, United States), D. Maselli (San Antonio, TX, United States), A. Yen (San Diego, CA, United States), K. Young (Aurora, CO, United States), G. Kinney (Aurora, CO, United States), M. Cho (Boston, MA, United States), R. San José Estépar, (Boston, MA, United States), A. Diaz (Boston, MA, United States)
Source: International Congress 2022 – Bronchiectasis
Session: Bronchiectasis
Session type: Oral Presentation
Number: 3755
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Dolliver (Boston, MA, United States), W. Wang (Boston, MA, United States), J. Orejas (Boston, MA, United States), D. Maselli (San Antonio, TX, United States), A. Yen (San Diego, CA, United States), K. Young (Aurora, CO, United States), G. Kinney (Aurora, CO, United States), M. Cho (Boston, MA, United States), R. San José Estépar, (Boston, MA, United States), A. Diaz (Boston, MA, United States). The ROSE criteria for coexistent COPD-bronchiectasis: association with future exacerbations and death. 3755
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|